ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04933	AGE-RAGE signaling pathway in diabetic complications	13/67	135/7206	2.09692970115e-10
ko05323	Rheumatoid arthritis	11/67	89/7206	3.96294692151e-10
ko04380	Osteoclast differentiation	12/67	134/7206	2.61428068896e-09
ko04060	Cytokine-cytokine receptor interaction	13/67	191/7206	1.53424995528e-08
ko05166	HTLV-I infection	14/67	292/7206	3.32394051771e-07
ko05132	Salmonella infection	8/67	98/7206	2.95648987754e-06
ko04218	Cellular senescence	10/67	177/7206	4.57735654786e-06
ko05418	Fluid shear stress and atherosclerosis	9/67	173/7206	2.77979292517e-05
ko05146	Amoebiasis	7/67	99/7206	3.30774804382e-05
ko05200	Pathways in cancer	15/67	492/7206	3.32644685471e-05
ko05144	Malaria	5/67	45/7206	5.47401693327e-05
ko05131	Shigellosis	6/67	82/7206	0.00010356967018
ko05212	Pancreatic cancer	6/67	83/7206	0.0001108318941
ko04668	TNF signaling pathway	7/67	120/7206	0.000113350196768
ko05210	Colorectal cancer	6/67	86/7206	0.000135078163556
ko05164	Influenza A	8/67	167/7206	0.00014334020704
ko05321	Inflammatory bowel disease (IBD)	5/67	56/7206	0.00015816605826
ko05205	Proteoglycans in cancer	10/67	271/7206	0.000178386924533
ko05142	Chagas disease (American trypanosomiasis)	7/67	130/7206	0.000187088664051
ko04210	Apoptosis	8/67	180/7206	0.000240329332708
ko05167	Kaposi's sarcoma-associated herpesvirus infection	8/67	191/7206	0.00035961554797
ko04659	Th17 cell differentiation	6/67	106/7206	0.000423879814483
ko04010	MAPK signaling pathway	10/67	321/7206	0.000689979023269
ko05130	Pathogenic Escherichia coli infection	5/67	77/7206	0.000703946793957
ko04015	Rap1 signaling pathway	9/67	278/7206	0.000996040941343
ko05161	Hepatitis B	7/67	173/7206	0.00105248459454
ko04144	Endocytosis	10/67	342/7206	0.00112418946155
ko04390	Hippo signaling pathway	7/67	188/7206	0.00170500946597
ko05211	Renal cell carcinoma	5/67	96/7206	0.00190151420853
ko04064	NF-kappa B signaling pathway	5/67	96/7206	0.00190151420853
ko05100	Bacterial invasion of epithelial cells	5/67	99/7206	0.00217793372132
ko05410	Hypertrophic cardiomyopathy (HCM)	5/67	100/7206	0.00227627864966
ko05414	Dilated cardiomyopathy	5/67	112/7206	0.0037238265706
ko04611	Platelet activation	6/67	163/7206	0.00390305012386
ko04672	Intestinal immune network for IgA production	3/67	37/7206	0.00476308330394
ko04530	Tight junction	7/67	228/7206	0.00501313254604
ko05140	Leishmaniasis	4/67	75/7206	0.00505768200781
ko04660	T cell receptor signaling pathway	5/67	124/7206	0.00573857020849
ko05145	Toxoplasmosis	5/67	126/7206	0.00613688348642
ko04510	Focal adhesion	7/67	240/7206	0.0066084675163
ko05220	Chronic myeloid leukemia	4/67	85/7206	0.00786246537782
ko04072	Phospholipase D signaling pathway	6/67	197/7206	0.00967344089972
ko05219	Bladder cancer	3/67	48/7206	0.00986082371263
ko04810	Regulation of actin cytoskeleton	7/67	264/7206	0.0109012017308
ko04670	Leukocyte transendothelial migration	5/67	151/7206	0.0128779134628
ko05416	Viral myocarditis	3/67	55/7206	0.0142847345165
ko04621	NOD-like receptor signaling pathway	5/67	157/7206	0.0150366623094
ko04350	TGF-beta signaling pathway	4/67	103/7206	0.0151650026424
ko04310	Wnt signaling pathway	5/67	181/7206	0.0260763376254
ko04912	GnRH signaling pathway	4/67	122/7206	0.0264446237351
ko04932	Non-alcoholic fatty liver disease (NAFLD)	5/67	182/7206	0.0266248561953
ko04151	PI3K-Akt signaling pathway	8/67	390/7206	0.027279662776
ko00363	Bisphenol degradation	1/67	3/7206	0.0276386783599
ko05152	Tuberculosis	5/67	187/7206	0.0294786608163
ko05143	African trypanosomiasis	2/67	32/7206	0.0353121581564
ko04610	Complement and coagulation cascades	3/67	79/7206	0.0368113698698
ko04137	Mitophagy - animal	3/67	82/7206	0.0404293371902
ko04921	Oxytocin signaling pathway	5/67	209/7206	0.0443045743298
ko04657	IL-17 signaling pathway	3/67	87/7206	0.0468452087798
ko05133	Pertussis	3/67	87/7206	0.0468452087798
ko04662	B cell receptor signaling pathway	3/67	88/7206	0.0481855337475
ko04745	Phototransduction - fly	2/67	38/7206	0.0483082148472